Collagen Solutions logo

COS - Collagen Solutions Share Price

6.63p 0.0  0.0%

Last Trade - 11:24am

Micro Cap
Market Cap £29.4m
Enterprise Value £28.7m
Revenue £4.01m
Position in Universe 1295th / 1803
Unlock COS Revenue
Relative Strength (%)
1m -2.00%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -3.58%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.97 3.13 3.95 3.50 4.15 4.01 5.30 +32.7%
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 March 2020, Collagen Solutions PLC revenues decreased 3% to £4M. Net loss increased from £1.7M to £3.4M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Sale of Group Companies - Gain/Loss decrease from £215K (income) to £0K, Selling/General/Admin. Expense increase of 3% to £3.6M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for COS
Graphical History


COS Revenue Unlock COS Revenue

Net Income

COS Net Income Unlock COS Revenue

Normalised EPS

COS Normalised EPS Unlock COS Revenue

PE Ratio Range

COS PE Ratio Range Unlock COS Revenue

Dividend Yield Range

COS Dividend Yield Range Unlock COS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
COS EPS Forecasts Unlock COS Revenue
Profile Summary

Collagen Solutions plc is a holding company. The Company is engaged in the business of supply, development and manufacture of medical grade collagen components and biomaterials. The Company's products and services are utilized in the research, diagnostics, medical devices and regenerative medicine markets. The Company's main products include Collagen and tissue biomaterials. The Company's product range includes raw tissue supply, including pericardium, which is used in heart valves and dural patches, various strengths of soluble and acid soluble collagen, acid swollen gels, freeze-dried powders, collagen sheets and fibrous collagen. The Company also manufactures Excellagen, a collagen gel used in wound care and cell therapy fields. Its services include product development and contract manufacturing. It offers a range of bovine spongiform encephalopathy (BSE)-free bovine biomaterials to meet customer specifications, including bone, cartilage and tendon, and veins and blood vessels.

Last Annual March 31st, 2020
Last Interim March 31st, 2020
Incorporated March 15, 2013
Public Since April 5, 2013
No. of Shareholders: n/a
No. of Employees: 48
Sector Healthcare
Industry Pharmaceuticals
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 444,182,981
Free Float (0.0%)
Eligible for
COS Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for COS
Upcoming Events for COS
Frequently Asked Questions for Collagen Solutions
What is the Collagen Solutions share price?

As of 11:24am, shares in Collagen Solutions are trading at 6.63p, giving the company a market capitalisation of £29.4m. This share price information is delayed by 15 minutes.

How has the Collagen Solutions share price performed this year?

Shares in Collagen Solutions are currently trading at 6.63p and the price has moved by 86.62% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Collagen Solutions price has moved by 0.125k% over the past year.

What are the analyst and broker recommendations for Collagen Solutions?

Of the analysts with advisory recommendations for Collagen Solutions, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Collagen Solutions is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Collagen Solutions next release its financial results?

Collagen Solutions is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Collagen Solutions dividend yield?

Collagen Solutions does not currently pay a dividend.

Does Collagen Solutions pay a dividend?

Collagen Solutions does not currently pay a dividend.

When does Collagen Solutions next pay dividends?

Collagen Solutions does not currently pay a dividend.

How do I buy Collagen Solutions shares?

To buy shares in Collagen Solutions you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Collagen Solutions?

Shares in Collagen Solutions are currently trading at 6.63p, giving the company a market capitalisation of £29.4m.

Where are Collagen Solutions shares listed? Where are Collagen Solutions shares listed?

Here are the trading details for Collagen Solutions:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: COS
What kind of share is Collagen Solutions?

Based on an overall assessment of its quality, value and momentum, Collagen Solutions is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Collagen Solutions share price forecast 2020?

Shares in Collagen Solutions are currently priced at 6.63p. At that level they are trading at 96.98% premium to the analyst consensus target price of 3.37.

Analysts covering Collagen Solutions currently have a consensus Earnings Per Share (EPS) forecast of -0.0014 for the next financial year.

How can I tell whether the Collagen Solutions share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Collagen Solutions. Over the past six months, the relative strength of its shares against the market has been 0.248k%. At the current price of 6.63p, shares in Collagen Solutions are trading at 95.74% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Collagen Solutions PE Ratio?

We were not able to find PE ratio data for Collagen Solutions.

Who are the key directors of Collagen Solutions?

Collagen Solutions's management team is headed by:

Malcolm Gillies - NID
Gillian Black - SEC
Jamal Rushdy - CEO
Hilary Spence - CFO
Christopher Brinsmead - NED
Tom Hyland - OTH
Lou Ruggiero - OTH
Wade Rosen - NED
Who are the major shareholders of Collagen Solutions?

Here are the top five shareholders of Collagen Solutions based on the size of their shareholding:

Rosen's Diversified Inc Corporation
Percentage owned: 17.87% (83.6m shares)
Evans (David Eric) Individual Investor
Percentage owned: 9.1% (42.6m shares)
Seneca Partners Ltd. Corporation
Percentage owned: 9.07% (42.4m shares)
Calculus Capital Limited Private Equity
Percentage owned: 6.55% (30.6m shares)
Gordon (Brett) Individual Investor
Percentage owned: 5.81% (27.2m shares)
Similar to COS
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.